- Assistant physician
Publications
2024
Treatment of Cerebral Histiocytosis With Low Dose of Cobimetinib: A Report of 2 Cases
Schubert C, Schiffmann I, Farschtschi S, Emile J, Friese M
NEUROL-NEUROIMMUNOL. 2024;11(3):e200233.
2023
Translation and validation of the multiple sclerosis walking scale 12 for the German population - the MSWS-12/D
Chorschew A, Kesgin F, Bellmann-Strobl J, Flachenecker P, Schiffmann I, Rosenthal F, Althoff P, Drebinger D, Arsenova R, Rasche L, Dorsch E, Heesen C, Paul F, Stellmann J, Schmitz-Hübsch T
HEALTH QUAL LIFE OUT. 2023;21(1):.
2022
Understanding Magnetic Resonance Imaging in Multiple Sclerosis (UMIMS): Development and Piloting of an Online Education Program About Magnetic Resonance Imaging for People With Multiple Sclerosis
Freund M, Schiffmann I, Rahn A, Chard D, Lukas C, Scheiderbauer J, Sippel A, Heesen C
FRONT NEUROL. 2022;13:.
Development and evaluation of evidence-based patient information handbooks about multiple sclerosis immunotherapies
Schneider A, Fasshauer E, Scheiderbauer J, Warnke C, Köpke S, Kasper J, Toussaint M, Temmes H, Hemmer B, Schiffmann I, Rahn A, Heesen C
MULT SCLER RELAT DIS. 2022;60:.
2021
Long-term prognostic counselling in people with multiple sclerosis using an online analytical processing tool
Kosch R, Schiffmann I, Daumer M, Lederer C, Scalfari A, Galea I, Scheiderbauer J, Rahn A, Heesen C
MULT SCLER J. 2021;27(9):1442-1450.
Continence and Complication Rates of Artificial Urinary Sphincter Devices (AMS 800) for Parkinson and Stroke Patients with Incontinence after Prostate Surgery: Retrospective Analysis of a Prospective Database
Maurer V, Stahlberg J, Schiffmann I, Marks P, Rosenbaum C, Soave A, Vetterlein M, Meyer C, Riechardt S, Fisch M, Ludwig T, Dahlem R
UROL INT. 2021;105(3-4):225-231.
2020
Construction of a User-Led Resource for People Transitioning to Secondary Progressive Multiple Sclerosis: Results of an International Nominal Group Study
Giovannetti A, Barabasch A, Giordano A, Quintas R, Barello S, Graffigna G, Alfieri S, Schiffmann I, Muche-Borowski C, Borreani C, Heesen C, Solari A
FRONT NEUROL. 2020;2020(11):798.
Conversion to secondary progressive multiple sclerosis: Multistakeholder experiences and needs in Italy
Giovannetti A, Pietrolongo E, Borreani C, Giordano A, Schiffmann I, Barabasch A, Heesen C, Solari A
PLOS ONE. 2020;15(2):e0228587.
Arzt-Patienten-Beziehung in der Neurologie
Heesen C, Rahn A, Schiffmann I, Zettl U, Sieb J
2020. Diagnostik und Therapie neurologischer Erkrankungen. Zettl U, Sieb J (eds.). 3. ed. Urban & Fischer, 535-548.
Assessing the effect of an evidence-based patient online educational tool for people with multiple sclerosis called UMIMS-understanding magnetic resonance imaging in multiple sclerosis: study protocol for a double-blind, randomized controlled trial
Schiffmann I, Freund M, Vettorazzi E, Stellmann J, Heyer-Borchelt S, D'Hooghe M, Häußler V, Rahn A, Heesen C
TRIALS. 2020;21(1):1008.
2019
Emotions towards magnetic resonance imaging in people with multiple sclerosis
Engels K, Schiffmann I, Weierstall R, Rahn A, Daubmann A, Pust G, Chard D, Lukas C, Scheiderbauer J, Stellmann J, Heesen C
ACTA NEUROL SCAND. 2019;139(6):497-504.
Using an online tool to convey long-term prognostic information to people with multiple sclerosis
Kosch R, Schiffmann I, Daumer M, Lederer C, Rahn A, Heesen C
MULT SCLER J. 2019;2019(25(7)):1057.
Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review
Rahn A, Köpke S, Stellmann J, Schiffmann I, Lukas C, Chard D, Heesen C
ACTA NEUROL SCAND. 2019;139(1):18-32.
Conversion to Secondary Progressive Multiple Sclerosis: Patient Awareness and Needs. Results From an Online Survey in Italy and Germany
Solari A, Giovannetti A, Giordano A, Tortorella C, Torri Clerici V, Brichetto G, Granella F, Lugaresi A, Patti F, Salvetti M, Pesci I, Pucci E, Centonze D, Danni M, Bonavita S, Ferraro D, Gallo A, Gajofatto A, Nociti V, Grimaldi L, Grobberio M, Lanzillo R, Di Giovanni R, Gregori S, Manni A, Pietrolongo E, Bertagnoli S, Ronzoni M, Compagnucci L, Fantozzi R, Allegri B, Arena S, Buscarinu M, Sabattini L, Quartuccio M, Tsantes E, Confaloneri P, Tacchino A, Schiffmann I, Rahn A, Kleiter I, Messmer Uccelli M, Barabasch A, Heesen C
FRONT NEUROL. 2019;10:916.
2018
Does cladribine have an impact on brain atrophy in people with relapsing remitting multiple sclerosis?
Schiffmann I, Scheiderbauer J, Riemann-Lorenz K, Heesen C
MULT SCLER J. 2018;24(10):1387-1388.
Letzte Aktualisierung aus dem FIS: 24.12.2024 - 03:53 Uhr